{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T12:38:52Z","timestamp":1791722332966,"version":"4.3.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Augsburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Population-based studies investigating the association between blood coagulation markers and non-alcoholic fatty liver disease (NAFLD) are rare. Thus, we aimed to investigate the relationship between the Fatty Liver Index (FLI) as a measure of hepatic steatosis and plasma concentrations of antithrombin III, D-dimer, fibrinogen D, protein C, protein S, factor VIII, activated partial thromboplastin time (aPTT), quick value and international thromboplastin time (INR) in the general population.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>After the exclusion of participants with anticoagulative treatment, 776 participants (420 women and 356 men, aged 54\u201374 years) of the population-based KORA Fit study with analytic data on hemostatic factors were included in the present analysis. Linear regression models were used to explore the associations between FLI and hemostatic markers, adjusted for sex, age, alcohol consumption, education, smoking status, and physical activity. In a second model, additional adjustments were made for the history of stroke, hypertension, myocardial infarction, serum non-HDL cholesterol levels, and diabetes status. In addition, analyses were stratified by diabetes status.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In the multivariable models (with or without health conditions), significantly positive associations with FLI were obtained for plasma concentrations of D-dimers, factor VIII, fibrinogen D, protein C, protein S, and quick value, while INR and antithrombin III were inversely associated. These associations were weaker in pre-diabetic subjects and largely disappeared in diabetic patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In this population-based study, an increased FLI is clearly related to changes in the blood coagulation system, possibly increasing the risk of thrombotic events. Due to a generally more pro-coagulative profile of hemostatic factors, such an association is not visible in diabetic subjects.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12944-023-01854-8","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T08:02:55Z","timestamp":1688025775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Association between fatty liver index and blood coagulation markers: a population-based study"],"prefix":"10.1186","volume":"22","author":[{"given":"Maximilian","family":"Iglesias Morcillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Freuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margit","family":"Heier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Teupser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Meisinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Linseisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,29]]},"reference":[{"key":"1854_CR1","doi-asserted-by":"crossref","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology [Internet]. 2016 [cited 2023 Apr 16];64:73\u201384. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26707365\/","DOI":"10.1002\/hep.28431"},{"key":"1854_CR2","doi-asserted-by":"crossref","unstructured":"Berardo C, Di Pasqua LG, Cagna M, Richelmi P, Vairetti M, Ferrigno A. Nonalcoholic fatty liver disease and non-alcoholic steatohepatitis: current issues and future perspectives in preclinical and clinical research. Int J Mol Sci [Internet]. 2020 [cited 2023 Apr 14];21:1\u201330. Available from: \/pmc\/articles\/PMC7766139\/.","DOI":"10.3390\/ijms21249646"},{"key":"1854_CR3","doi-asserted-by":"crossref","unstructured":"Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol [Internet]. 2020 [cited 2023 Apr 14];73:202\u20139. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32278004\/","DOI":"10.1016\/j.jhep.2020.07.045"},{"key":"1854_CR4","doi-asserted-by":"crossref","unstructured":"Marchesini G, Day CP, Dufour JF, Canbay A, Nobili V, Ratziu V et al. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol [Internet]. 2016 [cited 2023 Apr 14];64:1388\u2013402. Available from: http:\/\/www.journal-of-hepatology.eu\/article\/S0168827815007345\/fulltext","DOI":"10.1016\/j.jhep.2015.11.004"},{"key":"1854_CR5","doi-asserted-by":"crossref","unstructured":"Geier A, Tiniakos Di, Denk H, Trauner M. From the origin of NASH to the future of metabolic fatty liver disease. Gut [Internet]. 2021 [cited 2023 Apr 14];70:1570. Available from: \/pmc\/articles\/PMC8292567\/","DOI":"10.1136\/gutjnl-2020-323202"},{"key":"1854_CR6","doi-asserted-by":"crossref","unstructured":"Singh S, Allen AM, Wang Z, Prokop LJ, Murad MH, Loomba R. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol [Internet]. 2015 [cited 2023 Jun 14];13:643\u2013654.e9. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/24768810\/","DOI":"10.1016\/j.cgh.2014.04.014"},{"key":"1854_CR7","first-page":"501","volume":"37","author":"IS Idilman","year":"2016","unstructured":"Idilman IS, Ozdeniz I, Karcaaltincaba M. Hepatic steatosis: etiology, patterns, and quantification. Seminars in Ultrasound. CT and MRI. 2016;37:501\u201310.","journal-title":"CT and MRI"},{"key":"1854_CR8","doi-asserted-by":"crossref","unstructured":"Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6.","DOI":"10.1186\/1471-230X-6-33"},{"key":"1854_CR9","doi-asserted-by":"crossref","unstructured":"Younossi ZM, Loomba R, Rinella ME, Bugianesi E, Marchesini G, Neuschwander-Tetri BA et al. Current and Future Therapeutic Regimens for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Hepatology [Internet]. 2018 [cited 2023 Jun 5];68:361. Available from: \/pmc\/articles\/PMC6508084\/","DOI":"10.1002\/hep.29724"},{"key":"1854_CR10","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.2174\/1381612825666190117102111","volume":"24","author":"M Papatheodoridi","year":"2019","unstructured":"Papatheodoridi M, Cholongitas E. Diagnosis of non-alcoholic fatty liver Disease (NAFLD): current concepts. Curr Pharm Des. 2019;24:4574\u201386.","journal-title":"Curr Pharm Des"},{"key":"1854_CR11","doi-asserted-by":"publisher","unstructured":"Kurtz A, Pape H-C, Silbernagl S, Bondke Persson A, Brenner B, Burckhardt G et al. Physiologie [Internet]. Stuttgart: Georg Thieme Verlag; 2018 [cited 2022 Dec 29]. Available from: https:\/\/eref.thieme.de\/https:\/\/doi.org\/10.1055\/b-006-149284","DOI":"10.1055\/b-006-149284"},{"key":"1854_CR12","doi-asserted-by":"crossref","unstructured":"Northup PG, Caldwell SH. Coagulation in liver disease: a guide for the clinician. Clin Gastroenterol Hepatol [Internet]. 2013 [cited 2023 Apr 18];11:1064\u201374. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23506859\/","DOI":"10.1016\/j.cgh.2013.02.026"},{"key":"1854_CR13","unstructured":"Chaudhry R, Babiker HM, Physiology StatPearls. 2018 [cited 2022 Jul 15]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29489185"},{"key":"1854_CR14","doi-asserted-by":"crossref","unstructured":"Armandi A, Rosso C, Caviglia GP, Bugianesi E. Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease. Metabolites [Internet]. 2021 [cited 2023 Apr 14];11. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33800465\/","DOI":"10.3390\/metabo11030155"},{"key":"1854_CR15","doi-asserted-by":"publisher","first-page":"E3198","DOI":"10.1210\/clinem\/dgab124","volume":"106","author":"S H\u00f6rber","year":"2021","unstructured":"H\u00f6rber S, Lehmann R, Fritsche L, Machann J, Birkenfeld AL, H\u00e4ring HU, et al. Lifestyle intervention improves prothrombotic Coagulation Profile in individuals at high risk for type 2 diabetes. J Clin Endocrinol Metab. 2021;106:E3198\u2013207.","journal-title":"J Clin Endocrinol Metab"},{"key":"1854_CR16","doi-asserted-by":"crossref","unstructured":"Kirchberger I, Meisinger C. KORA-Studie: Ergebnisse aus 20 Jahren Gesundheitsforschung in Augsburg. Public Health Forum. 2012;20:19.e1-19.e3.","DOI":"10.1016\/j.phf.2012.06.010"},{"key":"1854_CR17","doi-asserted-by":"crossref","unstructured":"L\u00f6wel H, D\u00f6ring A, Schneider A, Heier M, Thorand B, Meisinger C. The MONICA Augsburg surveys - basis for prospective cohort studies. Gesundheitswesen. Gesundheitswesen; 2005.","DOI":"10.1055\/s-2005-858234"},{"key":"1854_CR18","unstructured":"World Health Organization. Obesity: preventing and managing the global epidemic : report of a WHO consultation. World Health Organization; 2000."},{"key":"1854_CR19","doi-asserted-by":"crossref","unstructured":"Zahn K, Linseisen J, Heier M, Peters A, Thorand B, Nairz F et al. Body fat distribution and risk of incident ischemic stroke in men and women aged 50 to 74 years from the general population. The KORA augsburg cohort study. PLoS ONE. 2018;13.","DOI":"10.1371\/journal.pone.0191630"},{"key":"1854_CR20","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1001\/archinte.162.1.82","volume":"162","author":"C Meisinger","year":"2002","unstructured":"Meisinger C, Thorand B, Schneider A, Stieber J, D\u00f6ring A, L\u00f6wel H. Sex differences in risk factors for incident type 2 diabetes mellitus: the MONICA Augsburg Cohort study. Arch Intern Med. 2002;162:82\u20139.","journal-title":"Arch Intern Med"},{"key":"1854_CR21","unstructured":"World Health Organisation. WHO Expert Committee on Biological Standardization. Guidelines forthromboplastins and plasma used to control oral anticoagulant therapy. 1999."},{"key":"1854_CR22","doi-asserted-by":"crossref","unstructured":"H\u00f6rber S, Lehmann R, Stefan N, Machann J, Birkenfeld AL, Wagner R et al. Hemostatic alterations linked to body fat distribution, fatty liver, and insulin resistance. Mol Metab. 2021;53.","DOI":"10.1016\/j.molmet.2021.101262"},{"key":"1854_CR23","doi-asserted-by":"crossref","unstructured":"Dahlb\u00e4ck B, Villoutreix BO. Molecular recognition in the protein C anticoagulant pathway. J Thromb Haemostasis J Thromb Haemost; 2003. p. 1525\u201334.","DOI":"10.1046\/j.1538-7836.2003.00299.x"},{"key":"1854_CR24","doi-asserted-by":"crossref","unstructured":"Rezende SM, Simmonds RE, Lane DA. Coagulation, inflammation, and apoptosis: different roles for protein S and the protein S-C4b binding protein complex. Blood Blood; 2004. p. 1192\u2013201.","DOI":"10.1182\/blood-2003-05-1551"},{"key":"1854_CR25","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1055\/s-0033-1349222","volume":"39","author":"P De Moerloose","year":"2013","unstructured":"De Moerloose P, Casini A, Neerman-Arbez M. Congenital fibrinogen disorders: an update. Semin Thromb Hemost. 2013;39:585\u201395.","journal-title":"Semin Thromb Hemost"},{"key":"1854_CR26","doi-asserted-by":"crossref","unstructured":"Mazurkiewicz-Pisarek A, P\u0142ucienniczak G, Ciach T, Plucienniczak A. The factor VIII protein and its function. Acta Biochim Pol Polskie Towarzystwo Biochemiczne; 2016. p. 11\u20136.","DOI":"10.18388\/abp.2015_1056"},{"key":"1854_CR27","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.avsg.2017.05.004","volume":"44","author":"H Kim","year":"2017","unstructured":"Kim H, Kim H, Park JH, Kim YH, Oh SJ, Suh BJ, et al. Alcohol consumption, high-density lipoprotein cholesterol, Antithrombin III, and body Mass Index are Associated with Great Saphenous Vein Reflux in the thigh. Ann Vasc Surg. 2017;44:307\u201316.","journal-title":"Ann Vasc Surg"},{"key":"1854_CR28","unstructured":"Tagariello G, Radossi P, Salviato R, Zardo M, De Valentin L, Basso M et al. Clinical relevance of isolated prolongation of the activated partial thromboplastin time in a cohort of adults undergoing surgical procedures. Blood Transfusion [Internet]. 2017 [cited 2023 Apr 16];15:557. Available from: \/pmc\/articles\/PMC5649965\/"},{"key":"1854_CR29","doi-asserted-by":"crossref","unstructured":"Tripodi A, Chantarangkul V, Martinelli I, Bucciarelli P, Mannucci PM. A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism. Blood [Internet]. 2004 [cited 2023 Apr 16];104:3631\u20134. Available from: https:\/\/ashpublications.org\/blood\/article\/104\/12\/3631\/89062\/A-shortened-activated-partial-thromboplastin-time","DOI":"10.1182\/blood-2004-03-1042"},{"key":"1854_CR30","doi-asserted-by":"crossref","unstructured":"Kotronen A, Joutsi-Korhonen L, Sevastianova K, Bergholm R, Hakkarainen A, Pietil\u00e4inen KH et al. Increased coagulation factor VIII, IX, XI and XII activities in non-alcoholic fatty liver disease. Liver Int [Internet]. 2011 [cited 2023 Mar 9];31:176\u201383. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/21134109\/","DOI":"10.1111\/j.1478-3231.2010.02375.x"},{"key":"1854_CR31","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/ajh.21429","volume":"84","author":"AR Folsom","year":"2009","unstructured":"Folsom AR, Delaney JAC, Lutsey PL, Zakai NA, Jenny NS, Polak JF, et al. Associations of factor VIIIc, D-dimer, and plasmin-antiplasmin with incident cardiovascular disease and all-cause mortality. Am J Hematol. 2009;84:349\u201353.","journal-title":"Am J Hematol"},{"key":"1854_CR32","doi-asserted-by":"publisher","first-page":"4930","DOI":"10.1016\/j.ijcard.2013.07.088","volume":"168","author":"O Akgul","year":"2013","unstructured":"Akgul O, Uyarel H. D-dimer: a novel predictive marker for cardiovascular disease. Int J Cardiol. 2013;168:4930\u20131.","journal-title":"Int J Cardiol"},{"key":"1854_CR33","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.3324\/haematol.2012.083410","volume":"98","author":"A di Castelnuovo","year":"2013","unstructured":"di Castelnuovo A, de Curtis A, Costanzo S, Persichillo M, Olivieri M, Zito F, et al. Association of D-dimer levels with all-cause mortality in a healthy adult population: findings from the MOLI-SANI study. Haematologica. 2013;98:1476\u201380.","journal-title":"Haematologica"},{"key":"1854_CR34","doi-asserted-by":"crossref","unstructured":"Ogresta D, Mrzljak A, Berkovic MC, Bilic-Curcic I, Stojsavljevic-Shapeski S, Virovic-Jukic L. Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications. J Clin Transl Hepatol [Internet]. 2022 [cited 2023 Apr 16];10:339\u201355. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35528987\/","DOI":"10.14218\/JCTH.2021.00268"},{"key":"1854_CR35","doi-asserted-by":"crossref","unstructured":"Virovi\u0107-Juki\u0107 L, Stojsavljevi\u0107-Shapeski S, Forga\u010d J, Kukla M, Mikola\u0161evi\u0107 I. Non-alcoholic fatty liver disease - a procoagulant condition? Croat Med J [Internet]. 2021 [cited 2023 Apr 16];62:25\u201333. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33660958\/","DOI":"10.3325\/cmj.2021.62.25"},{"key":"1854_CR36","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1007\/s10620-021-06954-y","volume":"66","author":"B Zou","year":"2021","unstructured":"Zou B, Yeo YH, Cheung R, Ingelsson E, Nguyen MH. Fatty Liver Index and Development of Cardiovascular Disease: findings from the UK Biobank. Dig Dis Sci. 2021;66:2092\u2013100.","journal-title":"Dig Dis Sci"},{"key":"1854_CR37","doi-asserted-by":"crossref","unstructured":"Lee CH, Han K, Do, Kim DH, Kwak MS. The repeatedly elevated fatty liver index is Associated with increased mortality: a Population-Based Cohort Study. Front Endocrinol (Lausanne). 2021;12.","DOI":"10.3389\/fendo.2021.638615"},{"key":"1854_CR38","doi-asserted-by":"crossref","unstructured":"Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology [Internet]. 2012 [cited 2023 Apr 16];142:1592\u2013609. Available from: http:\/\/www.gastrojournal.org\/article\/S0016508512004945\/fulltext","DOI":"10.1053\/j.gastro.2012.04.001"},{"key":"1854_CR39","doi-asserted-by":"crossref","unstructured":"Hess K. The vulnerable blood. Hamostaseologie [Internet]. 2015 [cited 2023 Apr 3];35:25\u201333. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29589350","DOI":"10.5482\/HAMO-14-09-0039"},{"key":"1854_CR40","doi-asserted-by":"crossref","unstructured":"Huang D, Refaat M, Mohammedi K, Jayyousi A, Al Suwaidi J, Abi Khalil C. Macrovascular Complications in Patients with Diabetes and Prediabetes. Biomed Res Int [Internet]. 2017 [cited 2023 Apr 16];2017. Available from: \/pmc\/articles\/PMC5697393\/","DOI":"10.1155\/2017\/7839101"},{"key":"1854_CR41","doi-asserted-by":"crossref","unstructured":"Alsharidah AS. Diabetes mellitus and diabetic nephropathy: a review of the literature on hemostatic changes in coagulation and thrombosis. Blood Res [Internet]. 2022 [cited 2023 Apr 3];57:101\u20135. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35620906\/","DOI":"10.5045\/br.2022.2021204"},{"key":"1854_CR42","doi-asserted-by":"crossref","unstructured":"Caine GJ, Stonelake PS, Lip GYH, Kehoe ST. The Hypercoagulable State of Malignancy: Pathogenesis and Current Debate. Neoplasia [Internet]. 2002 [cited 2023 Jun 14];4:465. Available from: \/pmc\/articles\/PMC1550339\/","DOI":"10.1038\/sj.neo.7900263"},{"key":"1854_CR43","doi-asserted-by":"crossref","unstructured":"Crocetto F, Pandolfo SD, Aveta A, Martino R, Trama F, Caputo VF et al. A Comparative Study of the Triglycerides\/HDL Ratio and Pseudocholinesterase Levels in Patients with Bladder Cancer. Diagnostics [Internet]. 2022 [cited 2023 Jun 14];12:431. Available from: https:\/\/www.mdpi.com\/2075-4418\/12\/2\/431\/htm.","DOI":"10.3390\/diagnostics12020431"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-023-01854-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-023-01854-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-023-01854-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T03:20:44Z","timestamp":1700364044000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-023-01854-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,29]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1854"],"URL":"https:\/\/doi.org\/10.1186\/s12944-023-01854-8","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,29]]},"assertion":[{"value":"19 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee of the Bavarian Chamber of Physicians and conducted according to the data protection requirements. The investigations were carried out in accordance with the Declaration of Helsinki. Study participants gave written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"83"}}